140 related articles for article (PubMed ID: 3499715)
1. [Role of T-lymphocyte mediators in the pathogenesis of psoriasis].
Kozin VM; Adamenko GP; Bogdanovich LI; Stel'machenok GE
Vestn Dermatol Venerol; 1987; (7):36-9. PubMed ID: 3499715
[No Abstract] [Full Text] [Related]
2. Serum inhibition of lymphocyte proliferative responses to mitogens in psoriasis.
Mobacken H; Lindholm L; Magnusson BL
Dermatol Monatsschr; 1986; 172(12):707-13. PubMed ID: 3493925
[No Abstract] [Full Text] [Related]
3. [Functional state of T-lymphocytes of the skin in patients with psoriasis].
Bogdanovich LI; Kozin VM; Adamchenko GP
Vestn Dermatol Venerol; 1984 Aug; (8):8-10. PubMed ID: 6385530
[No Abstract] [Full Text] [Related]
4. [Leukocyte migration inhibition test for functional evaluation of the T-lymphocyte population].
Bilynskaia KhZ; Loginskiĭ VE
Lab Delo; 1980; (5):316-7. PubMed ID: 6156295
[No Abstract] [Full Text] [Related]
5. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression.
Lew W; Bowcock AM; Krueger JG
Trends Immunol; 2004 Jun; 25(6):295-305. PubMed ID: 15145319
[No Abstract] [Full Text] [Related]
6. [Immunological reactivity of patients with simple psoriasis. I. Delayed hypersensitivity to phytohemagglutinin].
Kapińska-Mrówka M; Turowski G
Przegl Dermatol; 1980; 67(6):715-21. PubMed ID: 6972550
[No Abstract] [Full Text] [Related]
7. [Effect of antibiotics on human lymphocyte mitogenesis].
Rachkov SM; Bekbergenov BM; Korolev PN; Glezer GA
Antibiotiki; 1981 Jan; 26(1):55-8. PubMed ID: 6971073
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine stimulates the mitogen-driven lymphocyte proliferation in patients with psoriasis.
Schopf RE; Ockenfels HM; Schultewolter T; Morsches B
Dermatology; 1993; 187(2):100-3. PubMed ID: 8358095
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis as a T cell-mediated autoimmune disease.
Barker JN
Hosp Med; 1998 Jul; 59(7):530-3. PubMed ID: 9798540
[TBL] [Abstract][Full Text] [Related]
10. [Effects of opioids "in vivo" on blast transformation of T-lymphocytes induced with phytohemagglutinins].
Bonanno G; Bocchini G; Canevari A
Clin Ter; 1982 Feb; 100(3):241-7. PubMed ID: 6977429
[No Abstract] [Full Text] [Related]
11. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.
Bukulmez G; Akan T; Ciliv G
Eur J Dermatol; 2000 Jun; 10(4):274-6. PubMed ID: 10846253
[TBL] [Abstract][Full Text] [Related]
12. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
[TBL] [Abstract][Full Text] [Related]
13. [Humoral and cellular immunity in patients with psoriasis].
Ruszczak Z; Ciborska L; Czarnecki M; Bednarowicz G
Przegl Dermatol; 1985; 72(3):225-32. PubMed ID: 3878536
[No Abstract] [Full Text] [Related]
14. Perturbation of the human immune system by lithium.
Fernandez LA; Fox RA
Clin Exp Immunol; 1980 Sep; 41(3):527-32. PubMed ID: 7438566
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.
Zollner TM; Podda M; Pien C; Elliott PJ; Kaufmann R; Boehncke WH
J Clin Invest; 2002 Mar; 109(5):671-9. PubMed ID: 11877475
[TBL] [Abstract][Full Text] [Related]
16. [T-lymphocyte reactivity and the clinical condition of patients with ankylosing spondylitis].
Sadowska-Wróblewska M; Ryzewska A; Abgarowicz-Miłkowska T; Filipowicz-Sosnowska A; Garwolińska H; Górecka M; Kania A; Miaczyńska-Rusiniak B; Wierzchowska E
Reumatologia; 1981; 19(2):159-67. PubMed ID: 6976607
[No Abstract] [Full Text] [Related]
17. Activated T lymphocytes, interferon, and retrovirus-like particles in psoriatic lesions.
Bjerke JR; Haukenes G; Livden JK; Matre R; Degré M
Arch Dermatol; 1983 Dec; 119(12):955-6. PubMed ID: 6197033
[No Abstract] [Full Text] [Related]
18. The peripheral blood lymphocyte pattern in psoriasis preceded by an infection.
Lecewicz-Toruń B; Pietrzak A; Roliński J; Brzozowski W
Med Sci Monit; 2001; 7(5):889-93. PubMed ID: 11535929
[TBL] [Abstract][Full Text] [Related]
19. [Immunological aspects of psoriasis (author's transl)].
Vosmík F; Hausner P; Votava L; Fucíková T; Pekárek J
Cesk Dermatol; 1979 Jun; 54(3):123-31. PubMed ID: 316365
[No Abstract] [Full Text] [Related]
20. Treating psoriasis as a T-cell mediated disease.
Leonardi C
Manag Care; 2004 Apr; 13(4 Suppl Treating Psoriasis):1, 3-8. PubMed ID: 15282980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
